sponsored links

BTG’s esophageal cancer gel fails in trial (Reuters)

Sponsored Links

Reuters – British pharmaceutical group BTG said its OncoGel treatment did not show any impact on tumors in patients with esophageal cancer and it would not seek a partner for the product.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.